ATE202486T1 - Biodegradierbare medizinische polymer-anordnung mit supermolekularer-struktur - Google Patents

Biodegradierbare medizinische polymer-anordnung mit supermolekularer-struktur

Info

Publication number
ATE202486T1
ATE202486T1 AT95918178T AT95918178T ATE202486T1 AT E202486 T1 ATE202486 T1 AT E202486T1 AT 95918178 T AT95918178 T AT 95918178T AT 95918178 T AT95918178 T AT 95918178T AT E202486 T1 ATE202486 T1 AT E202486T1
Authority
AT
Austria
Prior art keywords
drug
polymer
supermolecular structure
biodegradable
cyclic compounds
Prior art date
Application number
AT95918178T
Other languages
English (en)
Inventor
Nobuhiko Yui
Nomigun Machi
Original Assignee
Nobuhiko Yui
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobuhiko Yui filed Critical Nobuhiko Yui
Application granted granted Critical
Publication of ATE202486T1 publication Critical patent/ATE202486T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AT95918178T 1994-09-24 1995-05-12 Biodegradierbare medizinische polymer-anordnung mit supermolekularer-struktur ATE202486T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25487294A JP3699141B2 (ja) 1994-09-24 1994-09-24 超分子構造の生体内分解性医薬高分子集合体及びその調製方法
PCT/JP1995/000909 WO1996009073A1 (en) 1994-09-24 1995-05-12 Biodegradable medicinal polymer assembly with supermolecular structure

Publications (1)

Publication Number Publication Date
ATE202486T1 true ATE202486T1 (de) 2001-07-15

Family

ID=17271012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918178T ATE202486T1 (de) 1994-09-24 1995-05-12 Biodegradierbare medizinische polymer-anordnung mit supermolekularer-struktur

Country Status (10)

Country Link
US (1) US5855900A (de)
EP (1) EP0730869B1 (de)
JP (1) JP3699141B2 (de)
KR (1) KR100387428B1 (de)
CN (1) CN1135720A (de)
AT (1) ATE202486T1 (de)
AU (1) AU2419995A (de)
CA (1) CA2176383A1 (de)
DE (1) DE69521491T2 (de)
WO (1) WO1996009073A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629494A1 (de) * 1996-07-09 1998-01-15 Schering Ag Pseudopolyrotaxane
JP2972861B2 (ja) * 1997-05-08 1999-11-08 北陸先端科学技術大学院大学長 超分子構造の血液適合性材料
US6730735B2 (en) * 1997-07-03 2004-05-04 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Conjugate of polyethylene glycol and chitosan
US6113880A (en) * 1997-12-17 2000-09-05 Schering Aktiengesellschaft Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
US7091192B1 (en) * 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
US7375096B1 (en) * 1998-12-04 2008-05-20 California Institute Of Technology Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
WO2000033885A1 (en) * 1998-12-04 2000-06-15 California Institute Of Technology Supramolecular complexes containing therapeutic agents
SG98393A1 (en) * 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
KR100714742B1 (ko) * 2000-07-03 2007-05-07 가부시키가이샤 재팬 티슈 엔지니어링 조직 재생용 기재, 이식용 재료 및 그의 제법
GB0018072D0 (en) * 2000-07-25 2000-09-13 Smith & Nephew Biodegradable supramolecular assemblies
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US7141540B2 (en) 2001-11-30 2006-11-28 Genta Salus Llc Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
AU2003216288B2 (en) 2002-02-13 2009-09-24 Duke University Modulation of immune response by non-peptide binding stress response polypeptides
US20030171573A1 (en) * 2002-02-27 2003-09-11 Nobuhiko Yui Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer
US20040162275A1 (en) * 2002-02-27 2004-08-19 Nobuhiko Yui Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer
KR20140070676A (ko) 2002-09-06 2014-06-10 인설트 테라페틱스, 인코퍼레이티드 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
CA2500661A1 (en) 2002-10-01 2004-04-15 Chiron Corporation Anti-cancer and anti-infectious disease compositions and methods for using same
BR0315198A (pt) * 2002-10-09 2005-08-30 Insert Therapeutics Inc Materiais e composições à base de ciclodextrina e usos relacionados aos mesmos
JP5070671B2 (ja) * 2003-04-25 2012-11-14 東レ株式会社 親水性材料およびその製造方法
US20070027075A1 (en) * 2003-06-09 2007-02-01 Smithrud David B Compositions and methods for targeted drug delivery
JP4747256B2 (ja) * 2003-11-04 2011-08-17 Jnc株式会社 複合刺激応答材料
US20050118124A1 (en) * 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
KR20070100820A (ko) 2005-01-31 2007-10-11 가부시키가이샤 바이오세렌택 경피 흡수 제제, 경피 흡수 제제 유지 시트 및 경피 흡수제제 유지 용구
SG124419A1 (en) * 2005-02-03 2006-08-30 Agency Science Tech & Res Polycations capable of forming complexes with nucleic acids
ES2277743B2 (es) 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
WO2007016757A1 (en) * 2005-08-05 2007-02-15 Orbus Pharma Inc. Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor
JP4521875B2 (ja) * 2005-08-31 2010-08-11 日産自動車株式会社 疎水性修飾ポリロタキサン
US20080026062A1 (en) * 2006-07-31 2008-01-31 Isaac Farr Pharmaceutical compositions including nano-sized active agent
US20080026040A1 (en) * 2006-07-31 2008-01-31 Isaac Farr Active agent-releasing dosage forms
KR100793268B1 (ko) 2006-10-02 2008-01-10 부산대학교 산학협력단 복합체의 제조방법
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
WO2010042815A2 (en) * 2008-10-09 2010-04-15 Duke University Vhh antibody fragments for use in the detection and treatment of cancer
US20100168044A1 (en) * 2008-12-26 2010-07-01 Devesh Kumar Misra Superparamagnetic nanoparticle encapsulated with stimuli responsive polymer for drug delivery
US8518405B2 (en) 2009-10-08 2013-08-27 The University Of North Carolina At Charlotte Tumor specific antibodies and uses therefor
BR112012012210B8 (pt) * 2009-11-23 2021-05-25 Cerulean Pharma Inc conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano
CA2927832C (en) * 2010-05-18 2021-03-23 Cerulean Pharma Inc. Cyclodextrin-containing polymer-therapeutic agent conjugates and their use
PL2651975T3 (pl) 2010-12-14 2018-04-30 Dso Nat Laboratories Ludzkie przeciwciało monoklonalne o swoistości względem białka e wirusa denga serotypu 1 i jego zastosowania
CA2821887C (en) 2010-12-16 2018-07-10 Sumitomo Seika Chemicals Co., Ltd. Method for producing pseudopolyrotaxane
EP2653479B1 (de) 2010-12-16 2015-12-02 Sumitomo Seika Chemicals Co. Ltd. Verfahren zur herstellung einer wässrigen pseudopolyrotaxandispersion
EP2653480B1 (de) * 2010-12-16 2016-08-10 Sumitomo Seika Chemicals Co. Ltd. Verfahren zur herstellung von raffiniertem polyrotaxan
CN103221431B (zh) 2010-12-16 2016-06-08 住友精化株式会社 准聚轮烷的制造方法
ES2552468T3 (es) * 2011-03-14 2015-11-30 Sumitomo Seika Chemicals Co. Ltd. Método de producción de un polirrotaxano hidrófilo modificado pulverizado
KR101817381B1 (ko) * 2011-03-14 2018-01-11 스미또모 세이까 가부시키가이샤 친수성 수식 폴리로탁산의 제조 방법
ES2620756T3 (es) * 2011-03-14 2017-06-29 Sumitomo Seika Chemicals Co., Ltd. Composición de polirotaxano
JP6196964B2 (ja) * 2012-03-30 2017-09-13 宇部興産株式会社 ヒドロキシアルキル化ポリロタキサンの製造方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
US11135316B2 (en) 2014-01-31 2021-10-05 Washington University Imaging and treatment of pathophysiologic conditions by Cerenkov radiation
US9974870B2 (en) 2014-06-09 2018-05-22 Washington University Compositions and methods for treatment and imaging using nanoparticles
JP6300926B2 (ja) * 2014-07-08 2018-03-28 国立大学法人大阪大学 自己修復性を有する高分子材料及びその製造方法
CA2956161A1 (en) 2014-07-23 2016-01-28 Ohio State Innovation Foundation Methods and compositions related to antibody fragments that bind to tumor-associated glycoprotein 72 (tag-72)
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
US10653798B2 (en) 2015-06-04 2020-05-19 University Of Florida Research Foundation, Inc. Electroactive supramolecular polymeric assemblies, methods of making electroactive supramolecular polymeric assemblies, and method of using electroactive supramolecular polymeric assemblies
JP2018531625A (ja) 2015-09-11 2018-11-01 ナセント バイオテック インコーポレイテッド 脳への向上した薬物送達の方法
US12514872B2 (en) 2015-11-04 2026-01-06 Duke University Polycationic polymers for use in treating and detecting cancer
US12447464B2 (en) 2016-12-22 2025-10-21 Duke University Polycationic microfibers and methods of using the same
US12319967B2 (en) 2019-08-21 2025-06-03 University Of Virginia Patent Foundation Methods and compositions for diagnosing and treating prostate cancer based on long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth
US11788091B2 (en) 2019-08-21 2023-10-17 University Of Virginia Patent Foundation Methods and compositions for diagnosing and treating prostate cancer based on long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth
JP7630158B2 (ja) * 2020-02-20 2025-02-17 国立大学法人 東京大学 ポリマー-環状分子構造体及びその製造方法
EP4232605A4 (de) 2020-11-11 2024-09-25 University of Virginia Patent Foundation Verfahren und zusammensetzungen zur diagnose und behandlung von prostatakrebs auf basis von langer nichtcodierender rna, die das lck-gen überlappen, das prostatakrebszellwachstum reguliert
EP4356929A1 (de) * 2022-10-19 2024-04-24 Universität Rostock Antifibrotische formulierung zur ophthalmischen behandlung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6089418A (ja) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd 徐放性制癌剤
JPS60112713A (ja) * 1983-11-21 1985-06-19 Sumitomo Chem Co Ltd 有用な徐放性注射剤
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates

Also Published As

Publication number Publication date
EP0730869B1 (de) 2001-06-27
KR100387428B1 (ko) 2003-10-04
AU2419995A (en) 1996-04-09
DE69521491T2 (de) 2002-03-28
JPH0892130A (ja) 1996-04-09
CA2176383A1 (en) 1996-03-28
US5855900A (en) 1999-01-05
EP0730869A4 (de) 1999-06-16
EP0730869A1 (de) 1996-09-11
DE69521491D1 (de) 2001-08-02
CN1135720A (zh) 1996-11-13
JP3699141B2 (ja) 2005-09-28
WO1996009073A1 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
DE69521491D1 (de) Biodegradierbare medizinische polymer-anordnung mit supermolekularer-struktur
DE3780218D1 (de) Tumor-nekrose-faktor-formulierung und ihre herstellung.
AU609051B2 (en) Starburst conjugates
NO884474L (no) Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem.
EP0179023A3 (en) With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments
ES2084768T3 (es) Entubado medico radiopaco, transparente opticamente.
CA2243649A1 (en) Bioresponsive pharmacologically-active polymers and articles made therefrom
ES2191403T3 (es) Tampon de algodon hidrofilo destinado a los cuidados de la piel y que presenta dos caras externas diferentes.
CA2085255A1 (en) Polyurethane-biopolymer composite
DE68916357D1 (de) Kern-Schale-Polymer, Zusammensetzung und Formteile davon.
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
CA2283648A1 (en) Polymeric carrier
ATE105490T1 (de) Prothesen mit knochenbindenden eigenschaften.
DE69003466D1 (de) Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
ITMI950440A0 (it) Materiali polimerici e articoli formati per la circolazione extracorporea non trombogenici e ad esaltata compatibilita' col sangue